HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kuo-Chen Wei Selected Research

Nuclear Receptor Co-Repressor 1

6/2022Correction to: Receptor-Interacting Protein 140 Enhanced Temozolomide-Induced Cellular Apoptosis Through Regulation of E2F1 in Human Glioma Cell Lines.
1/2022Receptor-Interacting Protein 140 Enhanced Temozolomide-Induced Cellular Apoptosis Through Regulation of E2F1 in Human Glioma Cell Lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kuo-Chen Wei Research Topics

Disease

65Neoplasms (Cancer)
03/2022 - 01/2003
39Glioma (Gliomas)
06/2022 - 01/2010
27Glioblastoma (Glioblastoma Multiforme)
01/2022 - 01/2003
24Brain Neoplasms (Brain Tumor)
01/2021 - 06/2008
7Meningioma (Meningiomas)
06/2021 - 01/2004
3Pituitary Neoplasms (Pituitary Adenoma)
01/2022 - 07/2013
3Astrocytoma (Pilocytic Astrocytoma)
01/2022 - 01/2005
3Residual Neoplasm
01/2022 - 01/2003
3Infections
03/2020 - 01/2015
3Seizures (Absence Seizure)
05/2019 - 01/2018
2Central Nervous System Diseases (CNS Diseases)
06/2021 - 01/2019
2Neurodegenerative Diseases (Neurodegenerative Disease)
09/2019 - 10/2016
2Paralysis (Palsy)
08/2019 - 01/2015
2Epilepsy (Aura)
05/2019 - 06/2012
2Lung Neoplasms (Lung Cancer)
11/2015 - 08/2015
1Growth Hormone-Secreting Pituitary Adenoma
01/2022
1Neurologic Manifestations (Neurological Manifestations)
12/2021
1Hyponatremia
01/2021
1Rupture
11/2020
1Gout
09/2020

Drug/Important Bio-Agent (IBA)

28Pharmaceutical PreparationsIBA
12/2021 - 05/2010
12Temozolomide (Temodar)FDA LinkGeneric
06/2022 - 06/2011
10Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2015
9Carmustine (FIVB)FDA Link
01/2016 - 01/2005
6EnzymesIBA
01/2022 - 08/2018
6Doxorubicin (Adriamycin)FDA LinkGeneric
06/2021 - 01/2012
4DNA (Deoxyribonucleic Acid)IBA
04/2019 - 10/2010
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 03/2013
3RNA (Ribonucleic Acid)IBA
11/2021 - 03/2012
3Biomarkers (Surrogate Marker)IBA
11/2021 - 01/2016
3IntegrinsIBA
06/2021 - 11/2015
3Messenger RNA (mRNA)IBA
01/2021 - 08/2018
3ErbB Receptors (EGF Receptor)IBA
01/2021 - 09/2013
3Bevacizumab (Avastin)FDA Link
03/2019 - 10/2016
3Epirubicin (Ellence)FDA LinkGeneric
01/2019 - 09/2013
3CateninsIBA
01/2016 - 08/2015
3OxidesIBA
08/2014 - 07/2013
2Nuclear Receptor Co-Repressor 1IBA
06/2022 - 01/2022
2AntioxidantsIBA
01/2022 - 08/2018
2Growth Hormone (Somatotropin)IBA
01/2022 - 07/2013
2Citrate (si)-Synthase (Synthase, Citrate)IBA
01/2022 - 08/2018
2ChromatinIBA
11/2021 - 11/2015
2Valproic Acid (Depakote)FDA LinkGeneric
01/2021 - 06/2012
2LigandsIBA
01/2020 - 01/2012
2Small Interfering RNA (siRNA)IBA
11/2019 - 01/2014
2Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
09/2019 - 10/2016
2Cell-Penetrating PeptidesIBA
04/2019 - 01/2019
2Therapeutic UsesIBA
04/2019 - 01/2015
26-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
04/2019 - 01/2019
2Liposomes (Liposome)IBA
01/2018 - 10/2016
2Folic Acid (Vitamin M)FDA LinkGeneric
11/2016 - 01/2012
2Contrast MediaIBA
10/2016 - 08/2014
2graphene oxideIBA
05/2015 - 01/2012
1Protons (Proton)IBA
03/2022
1Tocopherols (Tocopherol)IBA
01/2022
1theasinensin AIBA
01/2022
1ubiquinone 7IBA
01/2022
1ubiquinone 6IBA
01/2022
1ubiquinone 9IBA
01/2022
1Mitochondrial DNA (mtDNA)IBA
01/2022
1ubiquinone Q3IBA
01/2022
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
01/2022
1coenzyme Q10 (CoQ10)IBA
01/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022
1APG101IBA
12/2021
1TransposasesIBA
11/2021
1Genetic Markers (Genetic Marker)IBA
11/2021
1ApoferritinsIBA
06/2021
1Ferritins (Ferritin)IBA
06/2021
1Transferrin Receptors (Transferrin Receptor)IBA
06/2021
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2021
1FucosyltransferasesIBA
01/2021
1Proto-Oncogene Proteins c-metIBA
01/2021
1Hematoxylin (Haematoxylon)IBA
11/2020
1Eosine Yellowish-(YS) (Eosin)IBA
11/2020
1Sulfhydryl Compounds (Thiols)IBA
10/2020
1Glutathione (Reduced Glutathione)IBA
10/2020
1Uric Acid (Urate)IBA
09/2020
1Chondroitin Sulfates (Chondroitin Sulfate)IBA
02/2020
1crenolanibIBA
02/2020
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2020
1CalciumIBA
01/2020
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2020
1Conditioned Culture MediaIBA
01/2020
1CC ChemokinesIBA
01/2020

Therapy/Procedure

25Therapeutics
01/2022 - 06/2011
17Microbubbles
01/2021 - 01/2012
11Radiotherapy
03/2022 - 01/2005
8Drug Therapy (Chemotherapy)
01/2022 - 01/2011
8Craniotomy
12/2021 - 10/2006
3Adjuvant Radiotherapy
03/2022 - 01/2015
3Immunotherapy
01/2021 - 01/2015
3Aftercare (After-Treatment)
01/2021 - 01/2010
3Precision Medicine
01/2019 - 07/2013
2General Anesthesia
12/2021 - 01/2021
2Laminectomy
01/2018 - 01/2015
2Photothermal Therapy
09/2013 - 07/2013
2Particle Accelerators
07/2013 - 01/2004
1Patient Readmission
01/2021
1Sign Language
02/2020